California 2023-2024 Regular Session

California Assembly Bill AB1830

Introduced
1/12/24  
Introduced
1/12/24  
Refer
1/29/24  
Refer
1/29/24  
Report Pass
3/19/24  
Refer
3/21/24  
Refer
3/21/24  
Report Pass
4/10/24  
Report Pass
4/10/24  
Engrossed
4/18/24  
Engrossed
4/18/24  
Refer
4/18/24  
Refer
4/18/24  
Refer
5/1/24  
Report Pass
5/8/24  
Report Pass
5/8/24  
Refer
5/8/24  
Refer
5/8/24  
Report Pass
5/21/24  
Report Pass
5/21/24  
Refer
5/21/24  
Refer
5/21/24  
Report Pass
5/23/24  
Report Pass
5/23/24  
Refer
5/23/24  
Refer
5/23/24  
Report Pass
6/17/24  
Report Pass
6/17/24  
Refer
6/17/24  
Refer
6/17/24  
Report Pass
6/26/24  
Refer
6/26/24  
Refer
6/26/24  
Enrolled
8/26/24  
Enrolled
8/26/24  
Chaptered
9/28/24  

Caption

Corn masa flour and wet corn masa products: folic acid fortification.

Impact

This legislation is expected to improve public health outcomes by reducing the incidence of severe birth defects associated with folic acid deficiency. By mandating the fortification of these products, the bill aims to make crucial nutrients more accessible, particularly in communities that rely heavily on corn-based foods. The bill is also seen as a stride towards health equity, acknowledging the unique dietary practices and health challenges faced by Latino populations.

Summary

Assembly Bill 1830, introduced by Assemblymember Arambula, mandates the fortification of corn masa flour and wet corn masa products with folic acid to combat the high incidence of neural tube defects (NTDs) within Latino communities. Effective from January 1, 2026, corn masa flour must contain 0.7 milligrams of folic acid per pound, while wet corn masa products can include 0.4 milligrams. The bill addresses the historical exclusion of corn masa flour from federal fortification mandates, linking this gap to significant health disparities in Latino populations.

Sentiment

The sentiment around AB 1830 appears to be generally supportive, particularly among health advocacy groups who view it as a necessary step to improve maternal and infant health. However, there may be concerns from some businesses regarding the cost implications of reformulating products and compliance with new labeling requirements, especially those involved in small-scale food production. Nonetheless, the overarching view is that the potential public health benefits outweigh these concerns.

Contention

Despite the supportive sentiment, there are potential points of contention, particularly regarding the exemption of cottage food operations from the requirements set forth in the bill. While this exemption allows smaller producers to continue operating without the same strict requirements, it raises questions about consistency in public health standards and whether it could create loopholes that diminish the bill's intended health benefits. Ensuring adequate enforcement and compliance measures will be critical for the success of AB 1830.

Companion Bills

No companion bills found.

Similar Bills

CA AB2223

Cannabis: industrial hemp.

CA AB3029

Controlled substances.

CA SB6

Controlled substances: xylazine.

CA SB1502

Controlled substances: xylazine.

CA SB904

Controlled substances: treatment.

CA AB1468

Opioid Prevention and Rehabilitation Act.

CA AB1458

Cannabis testing laboratories.

CA AB2486

Opioid Prevention and Rehabilitation Act.